2016
DOI: 10.1515/rrlm-2016-0018
|View full text |Cite
|
Sign up to set email alerts
|

Pre-treatment antinuclear antibody positivity, therapeutic efficacy and persistence of biologics in rheumatoid arthritis

Abstract: Introduction: Rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 19 publications
0
1
0
Order By: Relevance
“…Tobacco use leads to a poor response to methotrexate administered in monotherapy. smoker's resistance to therapy may be caused by the pharmacokinetic interactions between drugs and tobacco constituents that stimulate the metabolic rate (4,5). smoking cessation may have a positive effect on ra patients, but the risk in former smokers is minimized only after 10 or even 20 years.…”
Section: Introductionmentioning
confidence: 99%
“…Tobacco use leads to a poor response to methotrexate administered in monotherapy. smoker's resistance to therapy may be caused by the pharmacokinetic interactions between drugs and tobacco constituents that stimulate the metabolic rate (4,5). smoking cessation may have a positive effect on ra patients, but the risk in former smokers is minimized only after 10 or even 20 years.…”
Section: Introductionmentioning
confidence: 99%